StockNews.com lowered shares of Kewaunee Scientific (NASDAQ:KEQU – Free Report) from a buy rating to a hold rating in a report issued on Tuesday morning.
Kewaunee Scientific Stock Performance
Shares of Kewaunee Scientific stock opened at $41.22 on Tuesday. The company has a quick ratio of 2.00, a current ratio of 2.53 and a debt-to-equity ratio of 0.48. The stock’s fifty day moving average is $36.51 and its two-hundred day moving average is $41.96. Kewaunee Scientific has a 52 week low of $22.10 and a 52 week high of $55.62. The company has a market capitalization of $118.38 million, a PE ratio of 6.62 and a beta of 0.80.
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last posted its quarterly earnings results on Wednesday, September 11th. The technology company reported $0.93 EPS for the quarter. The firm had revenue of $48.39 million for the quarter. Kewaunee Scientific had a net margin of 9.13% and a return on equity of 25.87%.
Institutional Trading of Kewaunee Scientific
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Recommended Stories
- Five stocks we like better than Kewaunee Scientific
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- Consumer Staples Stocks, Explained
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.